Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualizing Bypassing Agent Therapy Utilizing TEG in Hemophilia Patients with Inhibitors

NCT03002480 is registered in ClinicalTrials.gov with Children's Hospital Los Angeles as lead sponsor.

NCT NCT03002480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03002480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualizing Bypassing Agent Therapy Utilizing TEG in Hemophilia Patients with Inhibitors
Lead sponsor
Children's Hospital Los Angeles
Phase
Not applicable
Overall status
Withdrawn
Start date
January 31, 2017
Completion date
January 31, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a with inhibitors